BWXT selected for nuclear fuel deconversion award by U.S. Department of Energy
(LYNCHBURG, Va. – Oct. 8, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was selected by
(LYNCHBURG, Va. – Oct. 8, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was selected by
(LYNCHBURG, Va. – August 26, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from the National Nuclear Security Administration (NNSA) to complete
(OTTAWA, Ontario and Beloit, WI – July 22, 2024) – BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes,
BWXT and Wyoming Energy Authority Sign Cooperation Agreement to Examine Potential Construction Options in the State (LYNCHBURG, Va. – July 18, 2024) – BWX Technologies,
(LYNCHBURG, Va. – June 17, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced the award of the second phase of a contract with the
(LYNCHBURG, Va. – June 14, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract award from the U.S. Department of Energy, National Nuclear
Award Is Part of Larger Teaming Agreement Between BWXT and Rolls-Royce for Future Collaboration (LYNCHBURG, Va. – April 8, 2024) – BWX Technologies, Inc. (NYSE:
(LYNCHBURG, Va. – March 4, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated value of up to $45 billion
(LYNCHBURG, Va. – February 14, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was awarded a
Agreement Furthers BWXT Medical’s Position as a Global Leader in Actinium Supply Collaboration Enables Fusion to Produce High Purity Actinium-225 At Its Manufacturing Facility for